Consistent with previous studies,42 in which treatment with MST1/2 inhibitor XMU-MP-1 improves glucose tolerance in MLD-STZ induced diabetic model, we also observed significant improvement in intra-peritoneal glucose tolerance test in mice treated with IHMT-MST1-39 alone. Here, MST1 is linked to diabetes mellitus.